Effect of Exopolymers of Aureobasidium pullulans on Improving Osteoporosis Induced in Ovariectomized Mice |
SONG HEBOK
(TG Biotech Research Institute, Kyungpook National University)
PARK DONG CHAN (TG Biotech Research Institute, Kyungpook National University) DO GYUNG MIN (TG Biotech Research Institute, Kyungpook National University) HWANG SEUNG-LARK (TG Biotech Research Institute, Kyungpook National University) LEE WON KYU (TG Biotech Research Institute, Kyungpook National University) KANG HEUN-SOO (Metabolic Engineering Laboratories) PARK BOK-RYUN (Glucan Co., Bio 21 Center) JANG HEE-JEONG (Glucan Co., Bio 21 Center) SONG CHANG-WOO (Glucan Co., Bio 21 Center) PARK EUI KYUN (Skeletal Diseases Genome Research Center, Biomedical Research Institute, Kyungpook National University Hospital) KIM SHIN-YOON (Department of Orthopedic Surgery, Biomedical Research Institute, Kyungpook National University, Hospital) HUH TAE-LIN (Kyungpook National University, Department of Genetic Engineering) |
1 | Boivin, G. and P. J. Meunier. 2003. The mineralization of bone tissue: A forgotten dimension in osteoporosis research. Osteoporos. Int. 14 Suppl. 3: S19-24 DOI |
2 | Bone, H. G., D. Hosking, J. P. Devogelaer, J. R. Tucci, R. D. Emkey, R. P. Tonino, J. A. Rodriguez-Portales, R. W. Downs, J. Gupta, A. C. Santora, and U. A. Liberman. 2004. Alendronate phase III osteoporosis treatment study group. Ten years' experience with alendronate for osteoporosis in postmenopausal women. N. Engl. J. Med. 350: 1189-1199 DOI ScienceOn |
3 | Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337- 342 DOI ScienceOn |
4 | Strewler, G. J. 2004. Decimal point-osteoporosis therapy at the 10-year mark. N. Engl. J. Med. 350: 1172-1174 DOI ScienceOn |
5 | Yan, J., V. Vetvicka, Y. Xia, A. Coxon, M. C. Carroll, T. N. Mayadas, and G. D. Ross. 1999. Beta-glucan, a 'specific' biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18). J. Immunol. 163: 3045-3052 |
6 | Yang, B. K., J.-B. Park, and C. H. Song. 2002. Hypolipidemic effect of exo-polymer produced in submerged mycelial culture of five different mushrooms. J. Microbiol. Biotechnol. 12: 957-961 |
7 | Levi, G., V. Geoffroy, G. Palmisano, and M. C. de Vernejoul. 2002. Bones, genes and fractures: Workshop on the genetics of osteoporosis: From basic to clinical research. EMBO Rep. 3: 22-26 DOI ScienceOn |
8 | Bell, N. H. 2001. Advances in the treatment of osteoporosis. Curr. Drug Targets Immune Endocr. Metabol. Disord. 1: 93-102 DOI |
9 | Sakai, A., S. Nishida, N. Okimoto, Y. Okazaki, T. Hirano, T. Norimura, T. Suda, and T. Nakamura. 1998. Bone marrow cell development and trabecular bone dynamics after ovariectomy in ddy mice. Bone 23: 443-451 DOI ScienceOn |
10 | McClung, M. R., R. D. Wasnich, D. J. Hosking, C. Christiansen, P. Ravn, M. Wu, A. M. Mantz, J. Yates, P. D. Ross, and A. C. Santora. 2004. Prevention of postmenopausal bone loss: Six-year results from the early postmenopausal intervention cohort study. J. Clin. Endocrinol. Metab. 89: 4879-4885 DOI |
11 | Van Beek, E., E. Pieterman, L. Cohen, C. Lowik, and S. Papapoulos. 1999. Farnesyl pyrophosphate synthase is the molecular target of nitrogen-containing bisphosphonates. Biochem. Biophys. Res. Commun. 264: 108-111 DOI ScienceOn |
12 | Udagawa, N., N. Takahashi, T. Akatsu, H. Tanaka, T. Sasaki, T. Nishihara, T. Koga, T. J. Martin, and T. Suda. 1990. Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc. Natl. Acad. Sci. USA 87: 7260- 7264 |
13 | Lorden, J. F. and A. Caudle. 1986. Behavioral and endocrinological effects of single injections of monosodium glutamate in the mouse. Neurobehav. Toxicol. Teratol. 8: 509-519 |
14 | Kabir, M., J. M. Oppert, H. Vidal, F. Bruzzo, C. Fiquet, P. Wursch, G. Slama, and S. W. Rizkalla. 2002. Four-week low-glycemic index breakfast with a modest amount of soluble fibers in type 2 diabetic men. Metabolism 51: 819- 826 DOI ScienceOn |
15 | Lauritzen, D. B., R. Balena, M. Shea, J. G. Seedor, A. Markatos, H. M. Le, B. C. Toolan, E. R. Myers, G. A. Rodan, and W. C. Hayes. 1993. Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. J. Bone Miner. Res. 8: 871-879 DOI ScienceOn |
16 | Chappard, D., M. Petitjean, C. Alexandre, L. Vico, P. Minaire, and G. Riffat. 1991. Cortical osteoclasts are less sensitive to etidronate than trabecular osteoclasts. J. Bone Miner. Res. 6: 673-680 DOI ScienceOn |
17 | Hong, K. H., K. H. Jang, J. C. Lee, S. H. Kim, M. K. Kim, I. Y. Lee, S. M. Kim, Y. H. Lim, and S. A. Kang. 2005. Bacterial -glucan exhibits potent hypoglycemic activity via decrease of serum lipids and adiposity, and increase of UCP mRNA expression. J. Microbiol. Biotechnol. 9: 826-831 |
18 | Seo, H.-P., J.-M. Kim, H.-D. Shin, T.-K. Kim, H.-J. Chang, B.-R. Park, and J.-W. Lee. 2002. Production of -1,3/1,6-glucan by Aureobasidium pullulans SM-2001. Korean J. Biotechnol. Bioeng. 17: 376-380 |
19 | Stanford, C. M., P. A. Jacobson, E. D. Eanes, L. A. Lembke, and R. J. Midura. 1995. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J. Biol. Chem. 270: 9420-9428 DOI ScienceOn |
20 | Seedor, J. G., H. A. Quartuccio, and D. D. Thompson. 1991. The bisphosphonate alendronate (MK-217) inhibits bone loss due to ovariectomy in rats. J. Bone Miner. Res. 6: 339- 346 DOI ScienceOn |
21 | Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289: 1504-1508 DOI ScienceOn |
22 | Zhang, F. L. and P. J. Casey. 1996. Protein prenylation: Molecular mechanisms and functional consequences. Annu. Rev. Biochem. 65: 241-269 DOI ScienceOn |
23 | Park, E. K., Y. E. Lee, J. Y. Choi, S. H. Oh, H. I. Shin, K. H. Kim, S. Y. Kim, and S. Kim. 2004. Cellular biocompatibility and stimulatory effects of calcium metaphosphate on osteoblastic differentiation of human bone marrow-derived stromal cells. Biomaterials 25: 3403-3411 DOI ScienceOn |
24 | Rodan, G. A. and T. J. Martin. 2000. Therapeutic approaches to bone diseases. Science 289: 1508-1514 DOI |
25 | Tohamy, A. A., A. A. El-Ghor, S. M. El-Nahas, and M. M. Noshy. 2003. Beta-glucan inhibits the genotoxicity of cyclophosphamide, adriamycin and cisplatin. Mutat. Res. 541: 45-53 DOI |
26 | Kim, H. N., J. N. Lee, G. E. Kim, Y. M. Lee, C. H. Kim, and J. W. Sohn. 1999. Comparative study of immune-enhancing activity of crude and mannoprotein-free yeast-glucan preparations. J. Microbiol. Biotechnol. 9: 826-831 |